Effectiveness of antiviral treatment in preventing death in severe hospitalised influenza cases over six seasons
Ángela Domı́nguez(Instituto de Salud Carlos III), Cristina Rius(Centro de Investigación Biomédica en Red), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Arantxa Romero-Tamarit(Universitat Autònoma de Barcelona), Núria Torner(Centro de Investigación Biomédica en Red), Mireia Jané(Generalitat de Catalunya), Núria Soldevila(Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), Pere Godoy(Servicio Canario de la Salud), Joan A. Caylà
Cited by 27
Related Papers
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
|Critical Care|2009|382
The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis
|The Lancet|2020|357
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348